Records containing: Influenza
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-02Immunogenicity and Safety of a Quadrivalent Influenza Virus Subunit Vaccine in Subjects Aged 6-35 Months : A Randomized, Double-blind, Active-controlled Phase III Trial
-
CLINICAL_TRIALS study record update · 2026-01-02Phase 3 Double Blind Clinical Study of Effectiveness and Safety of Vero Cell-Derived, Trivalent, Seasonal Influenza Vaccine in Adults Aged 50 Years and Older
-
CLINICAL_TRIALS study record update · 2025-12-24Efficacy, Immunogenicity, and Safety of High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age
-
CLINICAL_TRIALS study record update · 2025-12-23A Phase 1/2, Randomized, Observer-blind, Active-Control Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-based Influenza and SARS-CoV-2 Multi-component Vaccines in Healthy Adults
-
CLINICAL_TRIALS study record update · 2025-12-19Incidence of Symptomatic and Asymptomatic Influenza Among Healthcare Workers : A Multicenter Cohort Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-17IDCRP-154: Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study
-
CLINICAL_TRIALS study record update · 2025-12-17Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Immunogenicity and Safety of One Dose of OVX836 Influenza Vaccine 480μg, After Intramuscular Administration in Healthy Subjects Aged 18-59 Years
-
CLINICAL_TRIALS study record update · 2025-12-10SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies
-
CLINICAL_TRIALS study record update · 2025-12-10Etude de Phase II évaluant l'immunogénicité et la tolérance d'un Vaccin inactivé Non adjuvanté Contre la Grippe A(H1N1)v Chez la Femme Enceinte
-
CLINICAL_TRIALS study record update · 2025-12-09The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study - a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-12-08Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients
-
CLINICAL_TRIALS study record update · 2025-12-04Identification, in Patients Admitted to Intensive Care for Severe Influenza Respiratory Infection, of a Predictive Biomarker of Respiratory Distress
-
CLINICAL_TRIALS study record update · 2025-12-04Cohort Study to Evaluate Clinical Expression and Maternofetal Consequences of A/H1N1 Influenza in Pregnant Women
-
CLINICAL_TRIALS study record update · 2025-12-04Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage in Patients Requiring Mechanical Ventilation in Intensive Care Unit
-
CLINICAL_TRIALS study record update · 2025-12-04A PHASE 3, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A COMBINED MODIFIED RNA VACCINE CANDIDATE AGAINST COVID-19 AND INFLUENZA IN HEALTHY INDIVIDUALS
-
CLINICAL_TRIALS study record update · 2025-12-03A Phase 3, Randomized, Modified Double-blind, 2-arm Study to Evaluate the Immunogenicity and Safety of High-Dose Inactivated Influenza Vaccine (IIV-HD) Compared With a Standard-dose Inactivated Influenza Vaccine (IIV-SD) in Participants 50 Through 64 Years of Age.
-
CLINICAL_TRIALS study record update · 2025-12-02A Phase 3, Randomized, Observer-Blind, Active-Control Study to Evaluate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adults ≥50 Years of Age
-
CLINICAL_TRIALS study record update · 2025-11-28Influenza & COVID-19 Obstetric and Perinatal Epidemiology (ICOPE) Study in India
-
CLINICAL_TRIALS study record update · 2025-11-26CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools
-
CLINICAL_TRIALS study record update · 2025-11-24Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
-
CLINICAL_TRIALS study record update · 2025-11-24Phase 2, Open-Label Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 and Comparator Seasonal Influenza Vaccines in Healthy Adults
-
CLINICAL_TRIALS study record update · 2025-11-21Randomized Open-Label Trial to Compare Immunogenicity of Egg-Based and Non-Egg Based Quadrivalent Influenza Vaccines Among Adults 18-64 Years of Age (US Flu Vaccine Effectiveness Serologic Study, 2018-19 and 2019-20)
-
CLINICAL_TRIALS study record update · 2025-11-18Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated Vaccine: A Single-Center, Open-Label, Single-Arm Clinical Study
-
CLINICAL_TRIALS study record update · 2025-11-17A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of Onradivir Tablets in Participants Aged 12 to 17 Years With Uncomplicated Influenza A.
-
CLINICAL_TRIALS study record update · 2025-11-05Influenza IMPRINT Cohort: Defining the Impact of Initial Influenza Exposure on Immunity in Infants